FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to immunology, and can be used in medicine for preventing and treating IgE mediated diseases. Disclosed is an Fc-fusion protein comprising an alpha chain of a high-affinity IgE receptor, a linker, an Fc region of IgG1, and the amino acid sequence presented in SEQ ID NO: 3, or an amino acid sequence comprising a lysine (K) deletion at the C-terminal of the amino acid sequence presented in SEQ ID NO: 3.
EFFECT: invention enables to obtain high-affinity IgE receptor fused to Fc α-chain stable at low pH.
4 cl, 3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IgE Fc RECEPTOR, A PHARMACEUTICAL COMPOSITION CONTAINING IT AND A METHOD FOR ITS PRODUCTION | 2019 |
|
RU2796162C2 |
FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2019 |
|
RU2728861C1 |
FUSED SERPINE POLYPEPTIDES AND METHODS OF THEIR APPLICATION | 2015 |
|
RU2746550C2 |
FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2012 |
|
RU2698655C2 |
STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION | 2016 |
|
RU2740672C2 |
NEW MODIFIED IMMUNOGLOBULIN Fc-FRAGMENT FUNCTION PROTEIN AND ITS USE | 2020 |
|
RU2800919C2 |
TREATMENT AND PREVENTION OF ALLERGY TO HOUSE DUST MITES | 2019 |
|
RU2815386C2 |
POLYVALENT AND POLYSPECIFIC GITR-BINDING FUSED PROTEINS | 2016 |
|
RU2753439C2 |
POLYVALENT MODULATORS OF REGULATORY T-CELLS | 2017 |
|
RU2769871C2 |
COMPOSITION CONTAINING PROBIOTICS AND POLYPEPTIDE HAVING BINDING AFFINITY RELATIVELY TO IgE AND ITS USE | 2019 |
|
RU2786578C2 |
Authors
Dates
2020-03-02—Published
2016-02-19—Filed